0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

A Proposal for a Scoring System for Hemoglobinuria Following Ethanolamine Oleate Sclerotherapy in Children with Venous Malformations

Published: Reading: 1 min

Topic overview

This study develops a scoring system to predict hemoglobinuria risk in pediatric patients undergoing ethanolamine oleate sclerotherapy for slow-flow vascular malformations. The research addresses a critical safety gap, as EO was originally designed for adult use and can cause renal complications in children.

Key takeaways

  • Macroscopic hemoglobinuria is the most common complication of ethanolamine oleate sclerotherapy in pediatric venous malformations.
  • EO sclerotherapy-induced hemoglobinuria can progress to acute renal failure in some cases.
  • Limited pediatric safety data exists for EO since it was originally developed for adult variceal treatment.
  • A scoring system can help identify children at higher risk for hemoglobinuria after EO sclerotherapy.
  • Risk stratification tools are needed to improve the safety profile of EO use in pediatric vascular malformation treatment.

Keywords

Ethanolamine Oleate Sclerotherapy Venous Malformations Hemoglobinuria Pediatric Interventional Radiology Vascular Anomalies Acute Renal Failure

Hashtags

#Sclerotherapy #VenousMalformations #PediatricRadiology #VascularAnomalies

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. A Proposal for a Scoring System for Hemoglobinuria Following Ethanolamine Oleate Sclerotherapy in Children with Venous Malformations. GlobalCastMD Medical Library. 2026-03-12. https://library.globalcastmd.com/article/11669

Comments

Loading comments...